Experienced in Systemic Sclerosis (SSc)

Dr. Quito O. Carr

Family Medicine
717 Encino Pl Ne, Suite 12, 
Albuquerque, NM 
Experienced in Systemic Sclerosis (SSc)
717 Encino Pl Ne, Suite 12, 
Albuquerque, NM 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Quito Carr is a primary care provider, practicing in Family Medicine in Albuquerque, New Mexico. Dr. Carr is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Systemic Sclerosis (SSc), Scleroma, and Parainfluenza.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Family Medicine
Licenses
Family Medicine in NM
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

717 Encino Pl Ne, Suite 12, Albuquerque, NM 87102

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase III, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Reactogenicity and Immune Response of a Single Intramuscular Dose of Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers
A Phase III, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Reactogenicity and Immune Response of a Single Intramuscular Dose of Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers
Enrollment Status: Terminated
Publish Date: April 20, 2025
Intervention Type: Biological, Drug
Study Phase: Phase 3
A Phase III, Randomized, Double-blind, Placebo-controlled Multi-country Study to Demonstrate Efficacy of a Single Dose of Unadjuvanted RSV Maternal Vaccine, Administered IM to Pregnant Women 18 to 49 Years of Age, for Prevention of RSV Associated LRTIs in Their Infants up to 6 Months of Age
A Phase III, Randomized, Double-blind, Placebo-controlled Multi-country Study to Demonstrate Efficacy of a Single Dose of Unadjuvanted RSV Maternal Vaccine, Administered IM to Pregnant Women 18 to 49 Years of Age, for Prevention of RSV Associated LRTIs in Their Infants up to 6 Months of Age
Enrollment Status: Terminated
Publish Date: February 20, 2025
Intervention Type: Biological, Drug
Study Drug: RSV Maternal vaccine
Study Phase: Phase 3
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
Enrollment Status: Completed
Publish Date: June 28, 2024
Intervention Type: Drug
Study Drugs: Galcanezumab, Rimegepant
Study Phase: Phase 4
A Phase II, Randomised, Observer-blind, Placebo Controlled Multi-country Study to Assess the Safety, Reactogenicity and Immunogenicity of a Single Intramuscular Dose of GSK Biologicals' Investigational RSV Maternal Unadjuvanted Vaccine (GSK3888550A), in Healthy Pregnant Women Aged 18 to 40 Years and Infants Born to Vaccinated Mothers
A Phase II, Randomised, Observer-blind, Placebo Controlled Multi-country Study to Assess the Safety, Reactogenicity and Immunogenicity of a Single Intramuscular Dose of GSK Biologicals' Investigational RSV Maternal Unadjuvanted Vaccine (GSK3888550A), in Healthy Pregnant Women Aged 18 to 40 Years and Infants Born to Vaccinated Mothers
Enrollment Status: Completed
Publish Date: December 13, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
View 3 Less Clinical Trials

2 Total Publications

Safety and Immunogenicity of an mRNA-1273 Booster in Children.
Safety and Immunogenicity of an mRNA-1273 Booster in Children.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 22, 2024
Similar Doctors
Experienced in Systemic Sclerosis (SSc)
Dr. Jennifer K. Phillips
Family Medicine
Experienced in Systemic Sclerosis (SSc)
Dr. Jennifer K. Phillips
Family Medicine

Unm Medical Group Inc

1 University Of New Mexico, 
Albuquerque, NM 
 (0.5 miles away)
Languages Spoken:
English
See accepted insurances

Jennifer Phillips is a primary care provider, practicing in Family Medicine in Albuquerque, New Mexico. Dr. Phillips is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are Systemic Sclerosis (SSc), Scleroma, Chronic Pain, and Maturity Onset Diabetes of the Young.

Experienced in Systemic Sclerosis (SSc)
Dr. Rachel D. Rankin
Family Medicine
Experienced in Systemic Sclerosis (SSc)
Dr. Rachel D. Rankin
Family Medicine

El Pueblo Health Services, Inc

Bernalillo, NM 
 (19.5 miles away)
505-867-2324
Experience:
17+ years
Languages Spoken:
English
See accepted insurances

Rachel Rankin is a primary care provider, practicing in Family Medicine in Bernalillo, New Mexico. Dr. Rankin has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are Opisthotonos, Muscle Spasms, Hypothyroidism, and Obesity in Children.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Carr's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile